Vaccine Characterization Using Advanced Technology - Mass spectrometry offers the potential for an unprecedented understanding of vaccines and why they fail. - BioPharm International

ADVERTISEMENT

Vaccine Characterization Using Advanced Technology
Mass spectrometry offers the potential for an unprecedented understanding of vaccines and why they fail.


BioPharm International


7. Gavin D. Perspectives on potency assays for complex biological products. 2007 WCBP, CMC Forum on Bioassays, 2007 Jan 28; Washington, DC.

8. WHO. Immunization, vaccines and biologicals: strategic plan 2006–2009. Geneva: 2005 Dec.

9. WHO. Recommendations for the preparation, characterization and establishment of international and other biological reference standards, final draft. Adopted by the 55th meeting of the WHO expert committee on biological standardization. Geneva: 2004 Nov 15–18.

10. International Conference on Harmonization. Q6B, Specifications: Test procedures and acceptance criteria for biotechnological/biological products. Geneva, Switzerland:1999 Mar 10.

11. ICH. Q5C, Quality of biotechnological products: stability testing of biotechnological/biological products. Geneva: 1995 Nov 30.

12. ICH. Q5D, Derivation and characterization of cell substrates used for production of biotechnological/biological products. Geneva: 1997 July 16.

13. ICH. Q5E, Comparability of biotechnological/biological products subject to changes in their manufacturing process.Geneva: 2004 Nov 18.

14. Girard MP et al. A review of human vaccine research and development: Malaria. Vaccine. 2007; 25:1567–1580.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here